Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors - Concepedia

Concepedia

Publication | Open Access

Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors

DOI Full Paper Access

29

Citations

5

References

2013

Year

Simeon Bowers, Anh P. Truong, Michael Ye, Danielle L. Aubele, Jennifer M. Sealy, R. Jeffrey Neitz, Roy K. Hom, Wayman Chan, Michael S. Dappen, Robert A. Galemmo,

Bioorganic & Medicinal Chemistry Letters

MedicineReceptor Tyrosine KinaseActive Polo-like Kinase-2Anti-cancer AgentDrug DevelopmentPharmacologyNovel TherapyBiomolecular EngineeringDrug Discovery

References

	Year	Citations

Page 1

Page 1